510(k) K240800
K240800 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "Access Intrinsic Factor Ab". The FDA issued a decision of Substantially Equivalent on May 3, 2024. The device falls under product code LIG (Radioassay, Intrinsic Factor Blocking Antibody), a Class II device regulated under 21 CFR 862.1810. Beckman Coulter, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 3, 2024
- Date Received
- March 25, 2024
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioassay, Intrinsic Factor Blocking Antibody
- Device Class
- Class II
- Regulation Number
- 862.1810
- Review Panel
- CH
- Submission Type